Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study

Farnesoid X receptor (FXR) modulates the expression of genes involved in lipid and carbohydrate homeostasis and inflammatory processes. This nuclear receptor is likely a tumor suppressor in several cancers, but its molecular mechanism of suppression is still under study. Several studies reported tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Jose, Sandra, Devi, Sreevidya S., Sajeev, Anjana, Girisa, Sosmitha, Alqahtani, Mohammed S., Abbas, Mohamed, Alshammari, Abdulrahman, Sethi, Gautam, Kunnumakkara, Ajaikumar B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2023
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977715/
https://www.ncbi.nlm.nih.gov/pubmed/35348180
http://dx.doi.org/10.1042/BSR20212791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977715/
https://www.ncbi.nlm.nih.gov/pubmed/35348180
http://dx.doi.org/10.1042/BSR20212791

Ejemplares similares